Charles River Laboratories International Inc
(NYSE:CRL)
$
214.2
25.52 (13.53%)
Market Cap: 10.95 Bil
Enterprise Value: 13.50 Bil
PE Ratio: 25.59
PB Ratio: 2.97
GF Score: 87/100 Charles River Laboratories International Inc at Jefferies London Healthcare Conference Transcript
Nov 16, 2022 / 10:20AM GMT
Release Date Price:
$239.39
(-4.27%)
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst
All right. We'll go ahead and get started. Good morning. Thank you for your attendance here at Jefferies London Healthcare Conference for 2022. I'm Dave Windley. I work in the U.S. healthcare research group, cover CROs and CDMOs, among some other sectors.
Very glad to -- pleased to have Charles River Laboratories here with us again. Appreciate your consistent attendance at this London Healthcare Conference. And Flavia Pease is the company's Chief Financial Officer -- Executive VP and Chief Financial Officer, having joined the company just 6 months ago.
Flavia H. Pease
Charles River Laboratories International, Inc. - Corporate Executive VP & CFO
That's right.
Questions & Answers
David Howard Windley
Jefferies LLC, Research Division - MD & Equity Analyst
And has been doing her deep dive into the company. So that really segues into my first question, which is about Flavia, your initial impressions and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot